A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.
Inclusion Criteria:
Exclusion Criteria:
Los Angeles, California 90033, United States
Chapel Hill, North Carolina 27516, United States
CABA, Buenos Aires C1060ABN, Argentina
Capital Federal, Buenos Aires 1425, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires C1425DKG, Argentina
CABA, Ciudad Autónoma de Buenos Aire C1430EGF, Argentina
Ciudad Autonoma de Buenos Aire, C1122AAF, Argentina
Ústí nad Labem, Ustecký Kraj 40113, Czechia
Nakagami-gun, Okinawa 903-0215, Japan
Nishi-ku Sakai-shi, Osaka 593 8324, Japan
Bunkyo-ku, Tokyo 113-8655, Japan
Itabashi-ku, Tokyo 173 8606, Japan
Itabashi-ku, Tokyo 173-8610, Japan
Shinagawa-KU, Tokyo 141-8625, Japan
Shinagawa, Tokyo 142-8555, Japan
Shinjuku-ku, Tokyo 160-0023, Japan
Shinjuku-ku, Tokyo 161-8521, Japan
Osielsko, Kuyavian-Pomeranian Voivodeship 86-031, Poland
Bialystok, Podlaskie Voivodeship 15-375, Poland
Lodz, Łódź Voivodeship, Poland
Smolensk, 214000, Russia
Sungnam-si, Gyeonggi-do 13496, South Korea
Taoyuan Hsien, 10508, Taiwan